Jpmorgan Chase & Co »

Sensei Biotherapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Sensei Biotherapeutics (SNSE) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $302 32 9.44

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Meta Platforms Common (META)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Broadcom Common (AVGO)
Alphabet Common (GOOG)
Tesla Common (TSLA)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Vanguard S&p 500 Etf Fund (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Oracle Corp Common (ORCL)
Abbvie Common (ABBV)

View all positions for Jpmorgan Chase & Co

Top funds holding Sensei Biotherapeutics

Ikarian Capital
Catalio Capital Management
Renaissance Technologies
UBS Group
SBI Securities
Jpmorgan Chase & Co
Morgan Stanley
Bnp Paribas Arbitrage, Snc

View all funds holding Sensei Biotherapeutics